Molecular aspects of apoptosis;Molekularni aspekti apoptoze

Acta Medica Croatica

Volumn 62, Issue 3, 2008, Pages 249-256

  Radović, Nikola ^a,b   Čučić, Snježana ^b   Altarac, Silvio ^b  

^a PLIVA CROATIA LTD   (Croatia)

^b Odjel za Farmakologiju I Neškodljivost Lijekova ^*  (Croatia)

Author keywords

Apoptosis; Caspase; Cell death; Cell surface death receptor; Mitochondria

Indexed keywords

CASPASE;

APOPTOSIS; CELL COUNT; CELL DEATH; CELL SURFACE; CELL SURVIVAL; CHROMATIN CONDENSATION; DNA FRAGMENTATION; EXTRACELLULAR MATRIX; HEMOSTASIS; PROTEIN DEGRADATION; REVIEW;

ANIMALS; APOPTOSIS; APOPTOSIS REGULATORY PROTEINS; CASPASES; HUMANS; MITOCHONDRIA; RECEPTORS, DEATH DOMAIN; SIGNAL TRANSDUCTION;

EID: 53049108903     PISSN: 13300164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (65)

1. Mooney A, Jobson T, Bacon R, Kitamura M, Savill J. Cytokines promote glomerular mesangjal cell survival in vitro by stimulus-dependent inhibition of apoptosis. J Immunol 1997; 159: 3949-60.
2. Mooney A, Jackson K, Bacon R, Streuli G, Edwards J, Bassuk J. Type IV collagen and laminin regulate glomerular mesangjal cell susceptibility to apoptosis via beta(1) integrin-mediated survival signals. Am J Pathol 1999; 155: 599-606.
3. Bailey RW, Aronow B, Harmony JAK, Griswold MD. Heat shock-initiated apoptosis is accelerated and removal of damaged cells is delayed in the testis of clusterin/Apoj knock-out mice. Biol Repro 2002; 66(4): 1042-53.
4. Cahuzac N, Baum W, Kirkin V i sur. Fas ligand is localized to membrane rafts, where it displays increased cell death-inducing activity. Blood 2006; 107(6): 2384-91.
5. Ortiz A, Lorz C, Egidio J. New kids in the block: the role of FasL and Fas in kidney damage. J Nephrol 1999; 12: 150-8.
6. Lorz C, Ortiz A, Justo P, Gonzales-Cuadrado S, Duque N, Gomez-Guerrero C, Egido J. Proapoptotic Fas ligand is expressed by normal kidney tubular epithelium and injured glomeruli. J Am Soc Nephrol 2000; 11: 1266-77.
7. Messmer UK, Briner VA, Pfeilschifter J. Tumor necrosis factor-alpha and lipopolysaccharide induce apoptotic cell death in bovine glomerular endothelial cells. Kidney Int 1999; 55: 2322-37.
8. Justo P, Sanz AB, Lorz C, Egido J, Ortiz A. Lethal activity of FADD death domain in renal tubular epithelial cells. Kidney Int 2006; 69: 2205-11.
9. Vaux DL, Korsmeyer SJ. Cell death in development. Cell 1999; 96: 245-54.
10. Jabbour AM, Puryer MA, Yu JY i sur. Human Bcl-2 cannot directly inhibit the Caenorhabditis elegans Apaf-1 homologue CED-3, but can interact with EGL-1. J Cell Sci 2006; 119: 2572-82.
11. Wagener A, Blottner S, Gortiz F, Streich WJ, Fickel J. Differential changes in expression of a and b FGF, IGF-1 and -2, and TGF-alpha during seasonal growth and involution of roe deer testis. Growth Factors 2003; 21: 95-102.
12. Lorz C, Justo P, Sanz AB, Egido J, Ortiz A. Role of Bcl-xL in paracetamol-induced tubular epithelial cell death. Kidney Int 2005; 67: 592-601.
13. Pothana S, Dong Z, Valery M. Apoptosis: Definition, mechanisms and relevance to disease. Am J Med 1999; 107: 489-506.
14. Alnemri ES, Livingston DJ, Nicholson DW. Human ICE/CED-3 protease nomenclature. Cell 1996; 87: 171.
15. Wyllie AH. Apoptosis. Br Med Bull 1997; 53: 478-80.
16. Wang SH, Van Antwerp M, Kuick R i sur. Microarray analysis of cytokine activation of apoptosis pathways in the thyroid. Endocrinology 2007; 148: 4844-52.
17. Erhart LM, Lankat-Buttgereit B, Schmidt H, Wenzel U, Daniel H, Goke R. Flavone initiates a hierarchical activation of the caspase-cascade in colon cancer cells. Apoptosis 2005; 10: 611-17.
18. Budihardjo I, Oliver H, Lutter M. Biochemical pathways of caspase activation during apoptosis. Annu Rev Cell Dev Biol 1999; 15: 269-90.
19. Nagata S. Apoptosis by death factor. Cell 1997; 88: 355-65.
20. Djerbi M, Malinowski MM, Yagita H, Zhivotovsky B, Grandien A. Participation of FLIP, RIP and Bcl-x(L) in fas-mediated T-cell death. Scand J Immunol 2007; 66(4): 410-21.
21. Takashina T, Nakayama M. Revival of apoptotic cells that display early-stage dynamic membrane blebbing. FEBS Lett 2007; 581: 4479-84.
22. Muzio M, Stockwell BR, Salvesen GS, Dixit VM. An induced proximity model for caspase-8 activation. J Biol Chem 1998; 273: 2926-30.
23. Tergaonkar V. NF kappa B pathway: A good signaling paradigm and therapeutic target. Int J Biochem Cell Biol 2006; 38: 1647-53.
24. Gamulin S. Poremećaji genskog izražaja. U: Gamulin S, Marušić M, Kovač Z. Patofiziologija. 5. izd. Zagreb: Medicinska naklada, 2002, 68-69.
25. Barkett M, Gilmore TD. Control of apoptosis by Rel/NF-êB transcription factors. Oncogene 1999; 18: 6910-24.
26. Deveaux QL, Reed JC. IAP-family proteins-supressors of apoptosis. Genes Dev 1999; 13: 239-52.
27. Stuart M, Rechner JHF, Fairchild RL. Apoptosis-programmed cell death. U: Walsh PC, Retik AB, Vaughan ED Jr, Wein AJ. Campbell' s Urology. 8. ed. Philadelphia, London, New York, St. Louis, Sydney, Toronto: Saunders, 2002, 325-7.
28. Liu X, Kim CN, Yang J, Jemmerson R, Wang X. Induction of apoptotic program in cell-free extracts: requirement for dATP and cytochrome c. Cell 1996; 86: 147-57.
29. Nakabayashi J, Sasaki A. A mathematical model for apoptosome assembly: The optimal cytochrome c/Apaf-1 ratio. J Theor Biol 2006; 242: 280-87.
30. Morizane Y, Honda R, Fukami K, Yasuda H. X-linked inhibitor of apoptosis functions as ubiquitin ligase toward mature caspase-9 and cytosolic Smac/DIABLO. J Biochem 2005; 137(2): 125-32..
31. Park HH, Lo YC, Lin SC, Wang L, Yang JK, Wu H. The death domain superfamily in intracellular signaling of apoptosis and inflammation. Annu Rev Immunol 2007; 25: 561-86.
32. Mikolajczyk J, Scott FL, Krajewski S, Sutherlin DP, Salvesen GS. Activation and substrate specificity of caspase-14. Biochemistry 2004; 43: 10560-9.
33. Seshagiri S, Miller L. Caenorhabditis elegans CED-4 stimulates CED-3 processing and CED-3 induced apoptosis. Curr Biol 1997; 7: 455-60.
34. Zou H, Li Y, Liu X, Wang X. An APAF-1 cytochrome c multimeric complex is a functional apoptosome that activates procaspase-9. J Biol Chem 1999; 274: 11549-56.
35. Franklin EE, Robertson JD. Requirement of Apaf-1 for mitochondrial events and the cleavage or activation of all procaspases during genotoxic stress-induced apoptosis. Biochem J 2007; 405: 115-22.
36. Kim R, Emi M, Tanabe K. Caspase-dependent and -independent cell death pathways after DNA damage. Oncol Rep 2005; 14: 595-99.
37. Chuang Y-H, Chuang W-L, Huang S-P, Huang C-H. Release of cytochrome-c and activation of caspases related to myocyte apoptosis in obstructed ureters in a rat model of obstructive uropathy. BJU International 2003; 32: 113-118.
38. Luo X, Budihardjo I, Zou H, Slaughter C, Wang X. Bid, a Bcl-2 interacting protein, mediates cytochrome-c release from mitochondria in response to activation of cell surface death receptors. Cell 1998; 94: 481-90.
39. Kuwana T, Smith JJ, Muzio M i sur. Apoptosis induction by caspasse-8 is amplified through the mitochondrial release of cytochrome-c. J Biol Chem 1998; 273: 16589-94.
40. Vander Heiden MG, Chandel NS, Wiliamson EK, Schumacher PT, Thompson CB. Bcl-xL regulates the membrane potential and volume homeostasis of mitochondria. Cell 1997; 91: 627-37.
41. Conradt B, Horvitz RH. The C. elegans protein egl-1 is required for programmed cell death and interacts with the Bcl-2-like protein CED-9. Cell 1998; 93: 519-29.
42. Kim R, Emi M, Tanabe K. Role of mitochondria as the gardens of cell death. Cancer Chemother Pharmacol 2006; 57: 545-53.
43. Garland JM, Rudin C. Cytochrome c induces caspase-dependent apoptosis in intact hematopoietic cells and overrides apoptosis suppression mediated by bcl-2, growth factor signalling MAP-kinase and malignant change. Blood 1998; 92: 1235-46.
44. Husari AW, Dbaibo GS, Bitar H i sur. Apoptosis and the activity of ceramide, Bax and Bcl-2 in the lungs of neonatal rats exposed to limited and prolonged hyperoxia. Respir Res 2006; 7: 100.
45. Borner C. The Bcl-2 protein family: sensors and checkpoints for life-or-death decision. Mol Immunol 2003; 39: 615-47.
46. Armstrong JS. Mitochondrial membrane permeabilization: the sine qua non for cell death. Bioessays 2006; 28: 253-60.
47. Walensky LD. Bcl-2 in the crosshairs: tipping the balance of life and death. Cell Death Differ 2006; 13: 1339-50.
48. Garrido C, Galluzzi L, Brunet M, Puig PE, Didelot C, Kroemer G. Mechanisms of cytochrome c release from mitochondria. Cell Death Differ 2006; 13: 1423-33.
49. Du C, Fang M, Li Y, Li L, Wang X. Smac, a mitochondrial protein that promotes cytochrome c-dependent caspase activation by eliminatring IAP inhibition. Cell 2000; 102: 33-42.
50. Narita M, Shimizu S, Ho T i sur. Bax interacts with the permeability transition pore to induce permeability transition and cytochrome c release in isolated mitochondria. Proc Natl Acad Sci USA 1998; 95: 14681-86.
51. Challa M, Malladi S, Pellock BJ i sur. Drosophila Omi, a mitochondrial-localized IAP antagonist and proapoptotic serine protease. Embo J 2007; 26: 3144-56.
52. Roy N, Deveraux QL, Takahashi R, Salvesen GS, Reed JC. The c-IAP and c-IAP-2 proteins are direct inhibitors of specific caspases. EMBO J 1997; 16: 6914-25.
53. Deveraux QL, Takahshi R, Salvesen GS, Reed JC. X-linked IAP is a direct inhibitor of cell-death proteases. Nature 1997; 388: 300-4.
54. Deveraux QL, Roy N, Stennicke HR, Van Arsdale T, Zhou Q. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J 1998; 17: 2215-23.
55. Chu ZL, McKinsey TA, Liu L, Gentry JJ, Malim MH, Ballard DW. Suppression of tumor necrosis factor-induced cell death by inhibition of apoptosis c-IAP-2 is under NF-kappa B control. Proc Natl Acad Sci USA 1997; 94: 10057-62.
56. Kovač Z. Smrt stanice. U: Gamulin S, Marušić M, Kovač Z i sur. Patofiziologija. 5. izd. Zagreb: Medicinska naklada, 2002,. 123-128.
57. Radović N. Učinak inhibitora angiotenzina II na fibrozu i apoptozu te aktivnost kaspaze-3 u bubrezima nakon podvezivanja uretera u štakora. Disertacija. Zagreb: Medicinski fakultet Sveučiliš ta u Zagrebu, 2005, 40.
58. Nussdorfer G, Mazzocchi G, Rebonto L. Long-term trophic effect of ACTH on rat adrenocortical cells. An ultrastructural, morphometric and autoradiographic study. Z Zellforsch Mikrosk Anat 1981; 115: 30-40.
59. Kerr JFR, Searle J. Deletion to Cells by Apoptosis during Castration-Induced Involution of the Rat Prostate. Virchows Arch Abt B ZeU Path 1973; 13: 87-102.
60. Stiens R, Helpap B. Die Regression der Ratten-Prostata nach Kastration: Histologische morphometrische und Zellkinetische Untersuchung unter Berûcksichtigung der Apoptose. Pathol Res Pract 1981; 172: 73-87.
61. Denmeade SR, Linx Xs, Isaacs JT Role of programmed (apoptotic) cell death during the progression and therapy for prostate cancer. Prostatae 1996; 28: 251-65.
62. Klahr S. Obstructive nephropathy. Intern Med 2000; 39: 355-61.
63. Truong LD, Sheikh-Hamad D, Chakraborty S, Suku WN. Cell apoptosis and proliferation in obstructive uropathy. Semin Nephrol 1998; 18: 641-651.
64. Truong LD, Petrusevska G, Yang G i sur. Cell apoptosis and proliferation in experimental chronic obstructive uropathy. Kidney Int 1996; 50: 200-7.
65. Truong LD, Yeon-Jin C, Chun Chui T i sur. Renal cell apoptosis in chronic obstructive uropathy: The roles of caspases. Kidney Int 2001; 60: 924-34.